Eisai Co., Ltd. (ESALF) Financials

ESALF Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 9.1 billion 3.3 billion
Dec. 31, 2025 9.5 billion 3.6 billion
Sept. 30, 2025 9.9 billion 3.8 billion
June 30, 2025 9.8 billion 3.9 billion

ESALF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -6.0 million ?
Dec. 31, 2025 202.1 million ?
Sept. 30, 2025 128.3 million ?
June 30, 2025 -24.0 million ?

ESALF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -20.5 million
Dec. 31, 2025 109.7 million
Sept. 30, 2025 69.6 million
June 30, 2025 101.1 million

ESALF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 1.5 billion 849.1 million -
Dec. 31, 2025 2.0 billion 861.0 million -
Sept. 30, 2025 2.1 billion 923.5 million -
June 30, 2025 2.0 billion 694.3 million -

ESALF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 ?
Dec. 31, 2025 1.8 million
Sept. 30, 2025 1.9 million
June 30, 2025 2.0 million

ESALF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 31.8 million 276.8 million 753.1 million -
Dec. 31, 2025 21.2 million 250.4 million 713.8 million -
Sept. 30, 2025 16.9 million 251.8 million 711.8 million -
June 30, 2025 31.7 million 271.0 million 699.9 million -

ESALF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.3 billion 327.7 million
Dec. 31, 2025 1.4 billion 326.4 million
Sept. 30, 2025 1.4 billion 312.0 million
June 30, 2025 1.4 billion 297.7 million

ESALF

Price: $26.18

52 week price:
23.88
35.83

Dividend Yield: 4.17%

5-year range yield:
1.56%
4.17%

Forward Dividend Yield: 3.89%

Payout Ratio: 132.31%

Payout Ratio Range:
-770.45%
99116.16%

Dividend Per Share: 1.02 USD

Earnings Per Share: 0.86 USD

P/E Ratio: 32.56

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Japan

Market Capitalization: 7.1 billion

Average Dividend Frequency: 2

Years Paying Dividends: 40

DGR3: 8.90%

DGR5: 3.87%

DGR10: 3.25%

DGR20: 7.31%

Links: